{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:29:59Z","timestamp":1787027399115,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13764-y","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:25:34Z","timestamp":1781184334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Carbapenem-resistant Enterobacterales infection at a South African paediatric hospital"],"prefix":"10.1186","volume":"26","author":[{"given":"Yemah","family":"Bockarie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Nuttall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsah Deepa","family":"Tootla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer","family":"Aniakwaa-Bonsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Eley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"3","key":"13764_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/aac.02183-19","volume":"64","author":"D Aguilera-Alonso","year":"2020","unstructured":"Aguilera-Alonso D, Escosa-Garc\u00eda L, Saavedra-Lozano J, Cercenado E, Baquero-Artigao F. Carbapenem-resistant Gram-negative bacterial infections in children. Antimicrob Agents Chemother. 2020, Feb, 21;64(3):10\u2013128. https:\/\/doi.org\/10.1128\/aac.02183-19.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"13764_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/QCO.0000000000000608","volume":"32","author":"AJ Brink","year":"2019","unstructured":"Brink AJ. Epidemiology of carbapenem-resistant Gram-negative infections globally. Curr Opin Infect Dis. 2019;32(6):609\u201316. https:\/\/doi.org\/10.1097\/QCO.0000000000000608.","journal-title":"Curr Opin Infect Dis"},{"key":"13764_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jgar.2023.10.008","volume":"35","author":"M Kedi\u0161alet\u0161e","year":"2023","unstructured":"Kedi\u0161alet\u0161e M, Phumuzile D, Angela D, Andrew W, Mae N-F. Epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Enterobacterales in Africa: a systematic review. J Glob Antimicrob Resist. 2023;35:297\u2013306. https:\/\/doi.org\/10.1016\/j.jgar.2023.10.008.","journal-title":"J Glob Antimicrob Resist"},{"issue":"6","key":"13764_CR4","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3201\/eid3006.231734","volume":"30","author":"HN Grome","year":"2024","unstructured":"Grome HN, Grass JE, Duffy N, Bulens SN, Ansari U, Campbell D, et al. Lutgring JD. Carbapenem-resistant and Extended-spectrum \u03b2-Lactamase\u2013Producing Enterobacterales in children, United States, 2016\u20132020. Emerg Infect Dis. 2024, Jun;30(6):1104\u201314. https:\/\/doi.org\/10.3201\/eid3006.231734.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"13764_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1473-3099(19)30755-8","volume":"20","author":"van Duin D","year":"2020","unstructured":"van Duin D, Arias CA, Komarow L, Chen L, Hanson BM, Weston G, et al. Multi-Drug resistant organism Network investigators. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. The Lancet Infect Dis. 2020, Jun;20(6):731\u201341. https:\/\/doi.org\/10.1016\/S1473-3099(19)30755-8.","journal-title":"The Lancet Infect Dis"},{"issue":"2","key":"13764_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jiph.2018.11.003","volume":"12","author":"E Castagnola","year":"2019","unstructured":"Castagnola E, Tatarelli P, Mesini A, Baldelli I, La Masa D, Biassoni R, et al. Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity. J Infect Public Health. 2019, Mar-Apr;12(2):270\u201374. https:\/\/doi.org\/10.1016\/j.jiph.2018.11.003.","journal-title":"J Infect Public Health"},{"issue":"4","key":"13764_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1473-3099(16)30517-5","volume":"17","author":"W Zingg","year":"2017","unstructured":"Zingg W, Hopkins S, Gayet-Ageron A, Holmes A, Sharland M, Suetens C, et al. ECDC PPS study group. Health-care-associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European centre for disease prevention and control point-prevalence survey. The Lancet Infect Dis. 2017, Apr;17(4):381\u201389. https:\/\/doi.org\/10.1016\/S1473-3099(16)30517-5.","journal-title":"The Lancet Infect Dis"},{"issue":"8","key":"13764_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.7499\/j.issn.1008-8830.2203145","volume":"24","author":"L Ye","year":"2022","unstructured":"Ye L, Zhang LY, Zhao Y, Gu B, Wu Z, Peng YZ. Clinical features and molecular epidemiology of carbapenem-resistant Enterobacterales infection in children. Zhongguo Dang Dai Er Ke Za Zhi. 2022, Aug, 15;24(8):881\u201386. English, Chinese. https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2203145.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"1","key":"13764_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4102\/sajid.v36i1.223","volume":"36","author":"BW Mzimela","year":"2021","unstructured":"Mzimela BW, Nkwanyana NM, Singh R. Clinical outcome of neonates with carbapenem-resistant Enterobacteriaceae infections at the King Edward VIII Hospital\u2019s neonatal unit, Durban, South Africa. South Afr J Infect Dis. 2021;36(1):223. https:\/\/doi.org\/10.4102\/sajid.v36i1.223.","journal-title":"South Afr J Infect Dis"},{"key":"13764_CR10","doi-asserted-by":"publisher","unstructured":"Ismail H, Zwane TBC, Du Toit E, da Costa RMA, Franceschi F, Perovic O. Carbapenem-resistant Enterobacterales among patients with bloodstream infections in South Africa: consolidated surveillance data, 2015\u20132021. PLoS ONE. 2025, Jul, 2;20(7):e0324262. https:\/\/doi.org\/10.1371\/journal.pone.0324262.","DOI":"10.1371\/journal.pone.0324262"},{"issue":"9","key":"13764_CR11","doi-asserted-by":"publisher","first-page":"877","DOI":"10.7196\/SAMJ.2016.v106i9.11028","volume":"106","author":"OO Malande","year":"2016","unstructured":"Malande OO, Du Plessis A, Rip D, Bamford C, Eley B. Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: a case series. S Afr Med J. 2016;106(9):877\u201382. https:\/\/doi.org\/10.7196\/SAMJ.2016.v106i9.11028.","journal-title":"S Afr Med J"},{"issue":"1","key":"13764_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4102\/sajid.v37i1.440","volume":"37","author":"L Greybe","year":"2022","unstructured":"Greybe L, Nuttall JJC, Brink AJ, Tootla HD. Descriptive analysis of infections due to New Delhi metallo-\u03b2-lactamase-producing Enterobacterales in children at Red cross War Memorial Children\u2019s hospital. South Afr J Infect Dis. 2022;37(1):440. https:\/\/doi.org\/10.4102\/sajid.v37i1.440.","journal-title":"South Afr J Infect Dis"},{"key":"13764_CR13","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.2147\/IDR.S369368","volume":"15","author":"W Wang","year":"2022","unstructured":"Wang W, Wang R, Zhang Y, Zeng L, Kong H, Bai X, et al. Ceftazidime-avibactam as salvage therapy in pediatric liver transplantation patients with infections caused by carbapenem-resistant Enterobacterales. IDR. 2022;15:3323\u201332. https:\/\/doi.org\/10.2147\/IDR.S369368.","journal-title":"IDR"},{"key":"13764_CR14","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.2147\/IDR.S389279","volume":"15","author":"M Hou","year":"2022","unstructured":"Hou M, Chen N, Dong L, Fang Y, Pan R, Wang W, et al. Molecular epidemiology, clinical characteristics and risk factors for bloodstream infection of multidrug-resistant Klebsiella pneumoniae infections in pediatric patients from Tianjin, China. IDR. 2022;15:7015\u201323. https:\/\/doi.org\/10.2147\/IDR.S389279.","journal-title":"IDR"},{"issue":"1","key":"13764_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jmii.2022.07.012","volume":"56","author":"P Fu","year":"2023","unstructured":"Fu P, Luo X, Shen J, He L, Rong H, Li C, et al. The molecular and epidemiological characteristics of carbapenemase-producing Enterobacteriaceae isolated from children in Shanghai, China, 2016\u20132021. J Microbiol Immunol Infect. 2023;56(1):48\u201356. https:\/\/doi.org\/10.1016\/j.jmii.2022.07.012.","journal-title":"J Microbiol Immunol Infect"},{"key":"13764_CR16","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.2147\/IDR.S394283","volume":"15","author":"P Liu","year":"2022","unstructured":"Liu P, Mai Y, Yuan W, Xie L, Ma W, Liu J, et al. Risk factors for mortality and antimicrobial regimens in pediatric intensive care unit patients with carbapenem-resistant Enterobacteriaceae infections: a six-year retrospective study. IDR. 2022;15:7307\u201316. https:\/\/doi.org\/10.2147\/IDR.S394283.","journal-title":"IDR"},{"issue":"2","key":"13764_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/antibiotics12020405","volume":"12","author":"Y Madney","year":"2023","unstructured":"Madney Y, Aboubakr S, Khedr R, Hafez H, Ahmed N, Elsheshtawy K, et al. Carbapenem-resistant Enterobacteriaceae (CRE) among children with cancer: predictors of mortality and treatment outcome. Antibiot (Basel). 2023;12(2):405. https:\/\/doi.org\/10.3390\/antibiotics12020405.","journal-title":"Antibiot (Basel)"},{"key":"13764_CR18","doi-asserted-by":"publisher","unstructured":"Nabarro LEB, Shankar C, Pragasam AK, Mathew G, Jeyaseelan V, Veeraraghavan B, et al. Clinical and bacterial risk factors for mortality in children with carbapenem-resistant Enterobacteriaceae bloodstream infections in India. The Pediatr Infect Disease J. 2017;36(6):e161\u201366. https:\/\/doi.org\/10.1097\/INF.0000000000001499.","DOI":"10.1097\/INF.0000000000001499"},{"issue":"10","key":"13764_CR19","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1093\/jac\/dkad255","volume":"78","author":"JF L\u00f3pez-Cubillos","year":"2023","unstructured":"L\u00f3pez-Cubillos JF, D\u00edaz A, C\u00e1rdenas VC, Camacho-Moreno G, Cantor E, Arcila EM, et al. Carbapenem resistance in Enterobacterales bloodstream infections among children with cancer or post-haematopoietic stem cell transplant: a retrospective cohort study. The J Antimicrob Chemother. 2023;78(10):2462\u201370. https:\/\/doi.org\/10.1093\/jac\/dkad255.","journal-title":"The J Antimicrob Chemother"},{"key":"13764_CR20","doi-asserted-by":"publisher","first-page":"983174","DOI":"10.3389\/fpubh.2022.983174","volume":"10","author":"S Ruvinsky","year":"2022","unstructured":"Ruvinsky S, Voto C, Roel M, Deschutter V, Ferraro D, Aquino N, et al. Carbapenem-resistant Enterobacteriaceae bloodstream infections: a case-control study from a pediatric referral hospital in Argentina. Front Public Health. 2022;10:983174. https:\/\/doi.org\/10.3389\/fpubh.2022.983174.","journal-title":"Front Public Health"},{"issue":"1","key":"13764_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12866-018-1166-z","volume":"18","author":"A Aquino-Andrade","year":"2018","unstructured":"Aquino-Andrade A, Merida-Vieyra J, Arias de la Garza E, Arzate-Barbosa P, De Colsa Ranero A. Carbapenemase-producing Enterobacteriaceae in Mexico: report of seven non-clonal cases in a pediatric hospital. BMC Microbiol. 2018;18(1):38. https:\/\/doi.org\/10.1186\/s12866-018-1166-z.","journal-title":"BMC Microbiol"},{"issue":"2","key":"13764_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.59213\/TP.2023.18894","volume":"4","author":"A Yah\u015fi","year":"2023","unstructured":"Yah\u015fi A, Bayhan GI, Arslan E, G\u00f6kd\u00f6l MY, Atay BN, Karaci\u011fer S, et al. Characteristics of Klebsiella bloodstream infections and risk factors for carbapenem-resistant Klebsiella infections in children. Trends Pediatrics. 2023;4(2):133\u201342. https:\/\/doi.org\/10.59213\/TP.2023.18894.","journal-title":"Trends Pediatrics"},{"issue":"2","key":"13764_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bjid.2015.12.004","volume":"20","author":"H Akturk","year":"2016","unstructured":"Akturk H, Sutcu M, Somer A, Aydin D, Cihan R, Ozdemir A, et al. Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensive care units: risk factors for progression to infection. The Braz J Infect Dis. 2016;20(2):134\u201340. https:\/\/doi.org\/10.1016\/j.bjid.2015.12.004.","journal-title":"The Braz J Infect Dis"},{"issue":"1","key":"13764_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12879-018-3160-3","volume":"18","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Guo LY, Song WQ, Wang Y, Dong F, Liu G. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients. BMC Infect Dis. 2018;18(1):248. https:\/\/doi.org\/10.1186\/s12879-018-3160-3.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"13764_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4102\/sajid.v38i1.487","volume":"38","author":"I Abrahams","year":"2023","unstructured":"Abrahams I, Dramowski A, Moloto K, Lloyd L, Whitelaw A, Bekker A. Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit. South Afr J Infect Dis. 2023;38(1):487. https:\/\/doi.org\/10.4102\/sajid.v38i1.487.","journal-title":"South Afr J Infect Dis"},{"issue":"3","key":"13764_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ijantimicag.2018.05.019","volume":"52","author":"EA Mitgang","year":"2018","unstructured":"Mitgang EA, Hartley DM, Malchione MD, Koch M, Goodman JL. Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: using diverse data to inform surveillance gaps. Int J Antimicrob Agents. 2018;52(3):372\u201384. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.05.019.","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"8","key":"13764_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.7196\/SAMJ.2021.v111i8.15762","volume":"111","author":"HD Tootla","year":"2021","unstructured":"Tootla HD, Copelyn J, Botha A, Brink AJ, Eley B. Using ceftazidime-avibactam for persistent carbapenem-resistant Serratia marcescens infection highlights antimicrobial stewardship challenges with new beta-lactam-inhibitor combination antibiotics. S Afr Med J. 2021;111(8):729\u201331. https:\/\/doi.org\/10.7196\/SAMJ.2021.v111i8.15762.","journal-title":"S Afr Med J"},{"issue":"10","key":"13764_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/jpids\/piae087","volume":"13","author":"HD Tootla","year":"2024","unstructured":"Tootla HD, Van Niekerk S, Gumede T, Nuttall J, Salie S, Eley B. Ceftazidime-avibactam treatment for carbapenemase-producing Enterobacterales in a South African Children\u2019s hospital. J Educ Chang Pediatr Infect Dis Soc. 2024;13(10):541\u201346. https:\/\/doi.org\/10.1093\/jpids\/piae087.","journal-title":"J Educ Chang Pediatr Infect Dis Soc"},{"key":"13764_CR29","unstructured":"Centers for Disease Control and Prevention (CDC). Healthcare Associated Infections (HAI). Carbapenem-resistant Enterobacterales (CRE). CRE technical information for public health, labs, healthcare facilities, and clinicians. Last updated November 2019 [Internet]. 2019. https:\/\/www.cdc.gov\/hai\/organisms\/cre\/technical-info.html. [2024 Feb 11]."},{"key":"13764_CR30","unstructured":"Centers for Disease Control and Prevention (CDC). Emerging infections program (EIP) Network Report. Healthcare-associated infections community interface activity. Multi-site Gram-negative surveillance initiative. Carbapenem-resistant Enterobacterales (CRE) surveillance, 2022. Available from: https:\/\/www.cdc.gov\/healthcare-associated-infections\/media\/pdfs\/2022-CRE-Report-508.pdf."},{"key":"13764_CR31","unstructured":"Centers for Disease Control and Prevention (CDC). National healthcare Safety Network (NHSN) patient Safety component manual. Chapter, 2: identifying healthcare-associated infections (HAI) for NHSN surveillance. Last updated January 2024 [Internet]. 2024. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/pcsmanual_current.pdf. [2024 Feb 11]."},{"issue":"24","key":"13764_CR32","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1001\/jama.297.24.2741","volume":"297","author":"van der Lee Jh","year":"2007","unstructured":"van der Lee Jh, Mokkink LB, Grootenhuis MA, Heymans HS, Offringa M, van der Lee JH. Definitions and measurement of chronic health conditions in childhood: a systematic review. JAMA. 2007;297(24):2741\u201351. https:\/\/doi.org\/10.1001\/jama.297.24.2741.","journal-title":"JAMA"},{"key":"13764_CR33","unstructured":"Tigecycline-injection products. FDA-Identified interpretive criteria. Available from https:\/\/www.fda.gov\/drugs\/development-resources\/tigecycline-injection-products."},{"issue":"8","key":"13764_CR34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.7196\/SAMJ.2022.v112i8.16351","volume":"112","author":"M Lowe","year":"2022","unstructured":"Lowe M, Shuping L, Perovic O. Carbapenem-resistant Enterobacterales in patients with bacteraemia at tertiary academic hospitals in South Africa, 2019 - 2020: an update. S Afr Med J. 2022;112(8):542\u201352. https:\/\/doi.org\/10.7196\/SAMJ.2022.v112i8.16351.","journal-title":"S Afr Med J"},{"issue":"7","key":"13764_CR35","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s10096-020-03845-4","volume":"39","author":"O Perovic","year":"2020","unstructured":"Perovic O, Ismail H, Quan V, Bamford C, Nana T, Chibabhai V, et al. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018. Eur J Clin Microbiol Infect Dis. 2020;39(7):1287\u201394. https:\/\/doi.org\/10.1007\/s10096-020-03845-4.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"13764_CR36","doi-asserted-by":"publisher","unstructured":"Kehoe K, Morden E, Zinyakatira N, Heekes A, Jones HE, Walter SR, et al. Lower respiratory tract infection admissions and deaths among children under 5 years in public sector facilities in the Western Cape province, South Africa, before and during the COVID-19 pandemic (2019 - 2021). S Afr Med J. 2024, Mar, 18;114(3):e1560. https:\/\/doi.org\/10.7196\/SAMJ.2024.v114i3.1560.","DOI":"10.7196\/SAMJ.2024.v114i3.1560"},{"key":"13764_CR37","doi-asserted-by":"publisher","unstructured":"Kehoe K, Morden E, Zinyakatira N, Heekes A, Jones HE, Walter SR, et al. Diarrhoeal admissions among children aged <5 years in public sector facilities in Western Cape Province, South Africa, before and during the COVID-19 pandemic (2019-2021). S Afr Med J. 2025 Aug 1;115(7):e2726. https:\/\/doi.org\/10.7196\/SAMJ.2025.v115i7.2726.","DOI":"10.7196\/SAMJ.2025.v115i7.2726"},{"key":"13764_CR38","doi-asserted-by":"publisher","unstructured":"Moloto K, Newton-Foot M, Whitelaw A, Dramowski A. Emergence and expansion of carbapenem resistant Enterobacterales in the Western Cape province, South Africa. PLoS ONE. 2024;19(8):e0309315. https:\/\/doi.org\/10.1371\/journal.pone.0309315.","DOI":"10.1371\/journal.pone.0309315"},{"issue":"1","key":"13764_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13756-017-0259-z","volume":"6","author":"AP Magiorakos","year":"2017","unstructured":"Magiorakos AP, Burns K, Rodr\u00edguez Ba\u00f1o J, Borg M, Daikos G, Dumpis U, et al. Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for disease Prevention and Control. Antimicrob Resist Infect Control. Antimicrob Resist Infect Control. 2017;6(1):113. https:\/\/doi.org\/10.1186\/s13756-017-0259-z.","journal-title":"Antimicrob Resist Infect Control"},{"key":"13764_CR40","doi-asserted-by":"publisher","unstructured":"Fisher M, Komarow L, Kahn J, Patel G, Revolinski S, Huskins WC, et al. Carbapenem-resistant Enterobacterales in children at 18 US Health care System study sites: clinical and molecular epidemiology from a prospective multicenter cohort study. Open Forum Infect Dis. 2024, Jan, 8;11(2). https:\/\/doi.org\/10.1093\/ofid\/ofad688.","DOI":"10.1093\/ofid\/ofad688"},{"key":"13764_CR41","doi-asserted-by":"publisher","unstructured":"Tootla HD, Prentice E, Moodley C, Marais G, Nyakutira N, Reddy K, et al. Carbapenem-resistant Enterobacterales among hospitalized patients in Cape Town, South Africa: clinical and microbiological epidemiology. JAC Antimicrob Resist. 2024;6(2):dlae051. https:\/\/doi.org\/10.1093\/jacamr\/dlae051.","DOI":"10.1093\/jacamr\/dlae051"},{"issue":"1","key":"13764_CR42","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1186\/s12879-017-2862-2","volume":"17","author":"H Lochan","year":"2017","unstructured":"Lochan H, Pillay V, Bamford C, Nuttall J, Eley B. Bloodstream infections at a tertiary level paediatric hospital in South Africa. BMC Infect Dis. 2017, Dec, 6;17(1):750. https:\/\/doi.org\/10.1186\/s12879-017-2862-2.","journal-title":"BMC Infect Dis"},{"key":"13764_CR43","doi-asserted-by":"publisher","unstructured":"Peirano G, Pitout JDD. Rapidly spreading Enterobacterales with OXA-48-like carbapenemases. J Clin Microbiol. 2025, Feb, 19;63(2):e0151524. https:\/\/doi.org\/10.1128\/jcm.01515-24.","DOI":"10.1128\/jcm.01515-24"},{"issue":"4","key":"13764_CR44","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3201\/eid2504.181482","volume":"25","author":"M Lowe","year":"2019","unstructured":"Lowe M, Kock MM, Coetzee J, Hoosien E, Peirano G, Strydom KA, et al. Klebsiella pneumoniae ST307 with bla OXA-181, South Africa, 2014\u20132016. Emerg Infect Dis. 2019, Apr;25(4):739\u201347. https:\/\/doi.org\/10.3201\/eid2504.181482.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"13764_CR45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4102\/sajid.v37i1.453","volume":"37","author":"AJ Brink","year":"2022","unstructured":"Brink AJ, Coetzee J, Richards GA, Feldman C, Lowman W, Tootla HD, et al. Best practices: appropriate use of the new \u03b2-lactam\/\u03b2-lactamase inhibitor combinations, ceftazidime-avibactam and ceftolozane-tazobactam in South Africa. South Afr J Infect Dis. 2022;37(1):453. https:\/\/doi.org\/10.4102\/sajid.v37i1.453.","journal-title":"South Afr J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13764-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13764-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13764-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:09:28Z","timestamp":1787026168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13764-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13764"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13764-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was completed in accordance with the Declaration of Helsinki. Approval to conduct the study was granted by the Human Research Ethics Committee (HREC), University of Cape Town, reference number: HREC\/REF 676\/2021 and the Research Committee of RCWMCH, reference number: RCC 311\/WC_2021112_030. Since this was a retrospective study using archived data, the HREC waived the need for informed consent. Patient details were anonymised before data analysis.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1515"}}